Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (731-740 of 992) with videos related to

Pageof 100
Sort By:
Haematologica|September 2, 2004
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's diseaseTeresa Marafioti, Cristina Mancini, Stefano Ascani, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Experimental Hematology & Oncology|August 28, 2015
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphomaEnrico Derenzini, Ilaria Iacobucci, Claudio Agostinelli, et al.
Blood|November 24, 1999
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patientsP L Zinzani, M Martelli, M Magagnoli, et al.
The American Journal of Surgical Pathology|August 15, 2014
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targetsClaudio Agostinelli, Hasan Rizvi, Jennifer Paterson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2022
Management of malignant cutaneous wounds in oncologic patientsMichela Starace, Miriam Anna Carpanese, Francesca Pampaloni, et al.
Discover Oncology|December 18, 2024
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patientsGiovanna Talarico, Andrea Franceschini, Alessandro Raveane, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 16, 2009
Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertensionChiara Mandò, Patrizio Antonazzo, Silvia Tabano, et al.
Breast (Edinburgh, Scotland)|December 11, 2022
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCLBenedetto Longo, Arianna Di Napoli, Giuseppe Curigliano, et al.
Experimental Hematology|June 14, 2002
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvestsMarco Ladetto, Paola Omedè, Selina Sametti, et al.
Pageof 100

Showing results (731-740 of 992) with videos related to

Sort By:
Pageof 100
Haematologica|September 2, 2004
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's diseaseTeresa Marafioti, Cristina Mancini, Stefano Ascani, et al.
Haematologica|November 2, 2018
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetMaria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Experimental Hematology & Oncology|August 28, 2015
Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphomaEnrico Derenzini, Ilaria Iacobucci, Claudio Agostinelli, et al.
Blood|November 24, 1999
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patientsP L Zinzani, M Martelli, M Magagnoli, et al.
The American Journal of Surgical Pathology|August 15, 2014
Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targetsClaudio Agostinelli, Hasan Rizvi, Jennifer Paterson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 7, 2022
Management of malignant cutaneous wounds in oncologic patientsMichela Starace, Miriam Anna Carpanese, Francesca Pampaloni, et al.
Discover Oncology|December 18, 2024
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patientsGiovanna Talarico, Andrea Franceschini, Alessandro Raveane, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 16, 2009
Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertensionChiara Mandò, Patrizio Antonazzo, Silvia Tabano, et al.
Breast (Edinburgh, Scotland)|December 11, 2022
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCLBenedetto Longo, Arianna Di Napoli, Giuseppe Curigliano, et al.
Experimental Hematology|June 14, 2002
Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvestsMarco Ladetto, Paola Omedè, Selina Sametti, et al.
Pageof 100